trending Market Intelligence /marketintelligence/en/news-insights/trending/cUM9IcgNpJS2pQ8SWXtfYQ2 content esgSubNav
In This List

Editas Medicine CFO to step down

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Editas Medicine CFO to step down

Editas Medicine Inc. said Andrew Hack would resign as the company's CFO to pursue other business interests, effective March 1, 2019.

The company said it is looking for a replacement.

Cambridge, Mass.-based Editas Medicine operates as a genome editing company.